0
Abstract: Slide Presentations |

SPIROMETRY IN OBESE AND NORMAL WEIGHT SMOKERS FREE TO VIEW

William T. Williams, MD*; Marcy F. Petrini, PhD; Akinyinka Ajelabi, MD
Author and Funding Information

G.V. Sonny Montgomery VA Medical Center, Jackson, MS


Chest


Chest. 2008;134(4_MeetingAbstracts):s50002. doi:10.1378/chest.134.4_MeetingAbstracts.s50002
Text Size: A A A
Published online

Abstract

PURPOSE:The purpose of this study was to determine the affect of obesity on spirometry in patients who smoke.

METHODS:We analyzed all consecutive spirometries that met the ATS standards in male smokers tested at our VA Medical Center pulmonary function laboratory. We eliminated patients with confounding lung and cardiac diseases. We compared 142 tests in patients with a BMI ≤; 25 Kg/m2 (mean ± SD = 22.1 ± 2.1) with 133 in patients with a BMI ≥ 30 (34.7 ± 4.6) using an unpaired t-test for variables and χ2 for abnormal rates. The two groups are not different in smoking history (60.2 vs. 61.1 pack years) or age (59.3 vs. 57.1). Power analysis showed that at least 100 patients in each group are necessary to detect a 10% difference in spirometric indices and abnormality rates with P < 0.05, adjusted for 6 comparisons. Variables are expressed as percent of predicted ± SD, using the NHANES III equations appropriate for race and sex.

RESULTS:There is a statistically significant decrease in the forced vital capacities (FVC) in obese vs. normal weight patients (84% ± 17% vs. 90% ± 16%, P = 0.023). The forced expired volumes in one second (FEV1) are not different (69% ± 20% vs. 64% ± 21%, P = 0.2). This results in a greater FEV1/FVC ratio in obese patients (63% ± 13% vs. 54% ± 15%; P < 0.0001). Similarly, the number of abnormal tests is greater in obese patients for FVC (39% vs 23%, P = 0.023). The number of abnormal FEV1 is the same (64% vs. 69%; P = 0.94). This results in lower abnormality of the FEV1/FVC in obese patients (78% vs 50%; P = 0.001).

CONCLUSION:Obesity masks obstruction in male smokers. For the same degree of obstruction as measured by the FEV1, the FEV1/FVC is greater in obese patients because their FVC is reduced.

CLINICAL IMPLICATIONS:In obese male smokers, other tests may be necessary to detect obstruction.

DISCLOSURE:William Williams, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, October 28, 2008

2:30 PM - 4:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543